Valvular heart disease in pregnancy

Hellenic Journal of Cardiology

Volumn 50, Issue 6, 2009, Pages 498-510

  Vasu, Sujethra ^a   Stergiopoulos, Kathleen ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anticoagulation; Cardiac disease; Women

Indexed keywords

AMIODARONE; AMOXICILLIN; AMPICILLIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENOXAPARIN; GENTAMICIN; HEPARIN; HYDRALAZINE; METOPROLOL; NITRATE; VANCOMYCIN; VERAPAMIL; WARFARIN;

ANESTHESIST; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; BIRTH DEFECT; BLOOD CLOTTING DISORDER; BRADYCARDIA; CARDIOLOGIST; CESAREAN SECTION; COUNSELING; DEATH; EMBRYOPATHY; FEMALE; FETUS OUTCOME; FETUS WASTAGE; HEART ATRIUM FIBRILLATION; HEART OUTPUT; HIGH RISK PREGNANCY; HUMAN; INTRAUTERINE GROWTH RETARDATION; MITRAL VALVE REPAIR; MITRAL VALVE STENOSIS; OBSTETRICS; PREGNANCY; RECOMMENDED DRUG DOSE; REVIEW; SIDE EFFECT; THROMBOEMBOLISM; UTEROPLACENTAL HYPOPERFUSION; VAGINAL DELIVERY; VALVULAR HEART DISEASE;

ANTIBIOTIC PROPHYLAXIS; ANTICOAGULANTS; BACTEREMIA; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEMODYNAMICS; HUMANS; OBSTETRIC LABOR COMPLICATIONS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RISK FACTORS;

EID: 73249135893     PISSN: 10117970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. van Oppen AC, van der Tweel I, Alsbach GP, Heethaar RM, Bruinse HW. A longitudinal study of maternal hemodynamics during normal pregnancy. Obstet Gynecol. 1996; 88: 40-46.
2. Elkayam U. Pregnancy and cardiovascular disease. In: Zipes DP, Libby P, Bonow RO, editors. Braunwald's Heart Disease. A Textbook of Cardiovascular Medicine. 7th ed. Philadelphia, PA: Elsevier; 2005. p. 1965.
3. Clark SL, Phelan JP, Greenspoon J, Aldahl D, Horenstein J. Labor and delivery in the presence of mitral stenosis: central hemodynamic observations. Am J Obstet Gynecol. 1985; 152: 984-988.
4. Elkayam U, Gleicher N. Cardiac evaluation during pregnancy. In: Elkayam U, editor. Cardiac Problems in Pregnancy. 3rd ed. New York: Wiley-Liss; 1998. p. 23-33.
5. Siu SC, Colman JM, Sorensen S, et al. Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation. 2002; 105: 2179-2184.
6. Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001; 104: 515-521.
7. Soler-Soler J, Galve E. Worldwide perspective of valve disease. Heart. 2000; 83: 721-725.
8. Reimold SC, Rutherford JD. Clinical practice. Valvular heart disease in pregnancy. N Engl J Med. 2003; 349: 52-59.
9. Briand M, Dumesnil JG, Kadem L, et al. Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment. J Am Coll Cardiol. 2005; 46: 291-298.
10. Stout KK, Otto CM. Pregnancy in women with valvular heart disease. Heart. 2007; 93: 552-558.
11. Hameed A, Karaalp IS, Tummala PP, et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol. 2001; 37: 893-899.
12. Les'niak-Sobelga A, Tracz W, KostKiewicz M, Podolec P, Pasowicz M. Clinical and echocardiographic assessment of pregnant women with valvular heart diseases-maternal and fetal outcome. Int J Cardiol. 2004; 94: 15-23.
13. Bhatla N, Lal S, Behera G, et al. Cardiac disease in pregnancy. Int J Gynaecol Obstet. 2003; 82: 153-159.
14. Elkayam U, Bitar F. Valvular heart disease and pregnancy part I: native valves. J Am Coll Cardiol. 2005; 46: 223-230.
15. Furman B, Shoham-Vardi I, Bashiri A, Erez O, Mazor M. Clinical significance and outcome of preterm prelabor rupture of membranes: population-based study. Eur J Obstet Gynecol Reprod Biol. 2000; 92: 209-216.
16. Campuzano K, Roqué H, Bolnick A, Leo MV, Campbell WA. Bacterial endocarditis complicating pregnancy: case report and systematic review of the literature. Arch Gynecol Obstet. 2003; 268: 251-255.
17. Bonow RO, Carabello BA, Chatterjee K et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol. 2006; 48: e1-148.
18. Nishimura RA, Carabello BA, Faxon DP, et al; American College of Cardiology/American Heart Association Task Force. ACC/AHA 2008 Guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Asssociation Task Force on Practice Guidelines. Circulation. 2008; 118: 887-896.
19. Silversides CK, Colman JM, Sermer M, Siu SC. Cardiac risk in pregnant women with rheumatic mitral stenosis. Am J Cardiol. 2003; 91: 1382-1385.
20. Barbosa PJ, Lopes AA, Feitosa GS, et al. Prognostic factors of rheumatic mitral stenosis during pregnancy and puerperium. Arq Bras Cardiol. 2000; 75: 215-224.
21. Zelop C, Heffner LF. The downside of cesarean delivery: short- and long-term complications. Clin Obstet Gynecol. 2004: 47; 386-393.
22. Cardiovascular drugs in pregnancy. In: Elkayam U, editor. Cardiac Problems in Pregnancy. 3rd ed. New York: Wiley-Liss; 1998. p. 339-450.
23. Mangione JA, Louren.o RM, dos Santos ES, et al. Longterm follow-up of pregnant women after percutaneous mitral valvuloplasty. Catheter Cardiovasc Interv. 2000; 50: 413-417.
24. Nercolini DC, da Rocha Loures Bueno R, Eduardo Guérios E, et al. Percutaneous mitral balloon valvuloplasty in pregnant women with mitral stenosis. Catheter Cardiovasc Interv. 2002; 57: 318-322.
25. de Souza JA, Martinez EE, Ambrose JA, et al. Percutaneous balloon mitral valvuloplasty in comparison with open mitral valve commissurotomy for mitral stenosis during pregnancy. J Am Coll Cardiol. 2001; 37: 900-903.
26. Ben Farhat M, Gamra H, Betbout F, et al. Percutaneous balloon mitral commissurotomy during pregnancy. Heart. 1997; 77: 564-567.
27. Esteves CA, Munoz JS, Braga S, et al. Immediate and longterm follow-up of percutaneous balloon mitral valvuloplasty in pregnant patients with rheumatic mitral stenosis. Am J Cardiol. 2006; 98: 812-816.
28. Patel JJ, Mitha AS, Hassen F, et al. Percutaneous balloon mitral valvotomy in pregnant patients with tight pliable mitral stenosis. Am Heart J. 1993; 125: 1106-1109.
29. Fawzy ME, Kinsara AJ, Stefadouros M, et al. Long-term outcome of mitral balloon valvotomy in pregnant women. J Heart Valve Dis. 2001; 10: 153-157.
30. Malhotra M, Sharma JB, Tripathii R, Arora P, Arora R. Maternal and fetal outcome in valvular heart disease. Int J Gynaecol Obstet. 2004; 84: 11-16.
31. Weiss Branko M, Von Segesser LK, Alon E, Seifert B, Turina MI. Outcome of cardiovascular surgery and pregnancy, a systematic review of the period 1984-96. Am J Obstet Gynecol. 1998; 179: 1643-1653.
32. Silversides CK, Colman JM, Sermer M, Farine D, Siu SC. Early and intermediate-term outcomes of pregnancy with congenital aortic stenosis. Am J Cardiol. 2003; 91: 1386-1389.
33. Bhargava B, Agarwal R, Yadav R, Bahl VK, Manchanda SC. Percutaneous balloon aortic valvuloplasty during pregnancy: use of the Inoue balloon and the physiologic antegrade approach. Cathet Cardiovasc Diagn. 1998; 45: 422-425.
34. Ben-Ami M, Battino S, Rosenfeld T, Marin G, Shalev E. Aortic valve replacement during pregnancy. A case report and review of the literature. Acta Obstet Gynecol Scand. 1990; 69: 651-653.
35. Ramanthan J, D'Alessia JG, Geller E, et al. Analgesia and anesthesia during pregnancy. In: Elkayam U, Gleicher N, editors. Cardiac Problems in Pregnancy. New York, NY: Wiley-Liss, 1998; p. 285-313.
36. Lind J, Wallenburg HC. The Marfan syndrome and pregnancy: a retrospective study in a Dutch population. Eur J Obstet Gynecol Reprod Biol. 2001; 98: 28-35.
37. Neilson G, Galea EG, Blunt A. Congenital heart disease and pregnancy. Med J Aust. 1970; 1: 1086-1088.
38. Hameed A, Yuodim K, Mahboob A, et al. Effect of the severity of pulmonary stenosis on pregnancy outcome: a case control study. Am J Obstet Gynecol 2004; 191: 93 (abstr).
39. Elkayam U, Bitar F. Valvular heart disease and pregnancy: part II: prosthetic valves. J Am Coll Cardiol. 2005; 46: 403-410.
40. Hung L, Rahimtoola SH. Prosthetic heart valves and pregnancy. Circulation. 2003; 107: 1240-1246.
41. de Boer K, ten Cate JW, Sturk A, Borm JJ, Treffers PE. Enhanced thrombin generation in normal and hypertensive pregnancy Am J Obstet Gynecol. 1989; 160: 95-100.
42. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med. 2000; 160: 191-196.
43. Wong V, Cheng CH, Chan KC. Fetal and neonatal outcome of exposure to anticoagulants during pregnancy. Am J Med Genet. 1993; 45: 17-21.
44. Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/ American College of Cardiology Foundation guide to warfarin therapy. J Am Coll Cardiol. 2003; 41: 1633-1652.
45. Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133: 844S-886S.
46. Hirsh J, Fuster V, American Heart Association Guide to anticoagulant therapy, part 2: oral anticoagulants. Circulation. 1994; 89:1469-1480.
47. Salazar E, Izaguirre R, Verdejo J, Mutchinick O. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses J Am Coll Cardiol. 1996; 27: 1698-1703.
48. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol. 1999; 33: 1637-1641.
49. Denbow CE, Matadial L, Sivapragasam S, Spencer H. Pregnancy in patients after homograft cardiac valve replacement. Chest. 1983; 3: 540-542.
50. Sadler L, McCowan L, White H, Stewart A, Bracken M, North R. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. BJOG. 2000; 107: 245-253.
51. Salazar E, Izaguirre R, Verdejo J, Mutchinick O. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. J Am Coll Cardiol. 1996; 27: 1698-1703.
52. Oran B, Lee-Parritz A, Ansell J. Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy. Thromb Haemost. 2004; 92: 747-751.
53. Elkayam U, Singh H, Irani A, et al. Anticoagulation in preg-nant women with prosthetic heart valve. J Cardiovasc Pharmacol Ther. 2004; 9: 107-115.
54. Mclintock C, North RA, White H. Prosthetic heart valves and pregnancy. Circulation. 2003; 108:159-160.
55. Lovenox injection (packet insert). Bridgewater, NJ: Aventis Pharmaceuticals; 2004.
56. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126: 627S-644S.
57. Barbour LA, Oja JL, Schultz LK. A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation. Am J Obstet Gynecol. 2004; 191: 1024-1029.
58. Spargias K, Manginas A, Pavlides G, et al. Transcatheter aortic valve implantation: first Greek experience. Hellenic J Cardiol. 2008; 49: 397-407.
59. Skalidis EI, Vardas PE. Coronary blood flow and flow reserve in aortic stenosis: effect of aortic valve therapy. Hellenic J Cardiol. 2008; 49: 379-381.